Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,985 active trials259 approved drugs4,032 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04290546 | CIML NK Cell in Head & Neck Cancer | completed | Phase 1 | 11 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT05675059 | Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients | completed | N/A | 80 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT05754658 | African Cancer Genome: GMD | completed | — | 854 | Fox Chase Cancer CenterOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT06068257 | Tumor-Derived FGF19 | completed | — | 119 | University of Central FloridaOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT06076135 | Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors(ILDR-01) | completed | Phase 2 | 24 | Chuangzhen ChenOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07040514 | 24GUT540 : Meeting of Breast Cancer Patients and Pathologists | completed | N/A | 21 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07040943 | Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors. | completed | Phase 1 | 6 | West China HospitalOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07654036 | Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision Support in Lung Cancer | completed | N/A | 8 | Peking University People's HospitalOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07736131 | Learning Curve of SILS in CRC(SILS) | completed | — | 280 | Ruijin HospitalOTHER | 0 | Jul 30, 2026 | clinicaltrials |
| NCT00458536 | Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF | completed | Phase 1 / Phase 2 | 36 | Beth Israel Deaconess Medical CenterOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT00505063 | Prospective Trial of Vaccine Responses in Childhood Cancer Survivors | completed | Phase 2 | 75 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT01542021 | Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer | completed | N/A | 41 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT03264131 | BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma | completed | Phase 2 | 16 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT04458831 | A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)(IONA-MM) | completed | — | 583 | SanofiINDUSTRY | 21 | Jul 29, 2026 | clinicaltrials |
| NCT04763902 | Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer(TIMESPAN) | completed | N/A | 39 | University of UtahOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT05037149 | Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors | completed | Phase 1 | 50 | SirnaomicsINDUSTRY | 1 | Jul 29, 2026 | clinicaltrials |
| NCT05258279 | Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations | completed | Phase 2 | 30 | Juntendo UniversityOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT05563870 | Endoscopy and Radiology-guided Ablation for Inoperable Cholangiocarcinoma(COMBO-RFA) | completed | N/A | 26 | Clinical Hospital ColentinaOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT06075758 | A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer | completed | — | 175 | Novartis PharmaceuticalsINDUSTRY | 3 | Jul 29, 2026 | clinicaltrials |
| NCT06725342 | HNSCC Immuno-genomics Project | completed | — | 401 | Hellenic Cooperative Oncology GroupOTHER | 0 | Jul 29, 2026 | clinicaltrials |
| NCT07454967 | Development of a Multimodal AI System for GIST Management | completed | — | 300 | Qun ZhaoOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT07590505 | Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer(ULTIMO) | completed | Phase 3 | 132 | Cancer Research AntwerpOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT01833650 | The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer | completed | N/A | 120 | Cyprus University of TechnologyOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT03030066 | Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas | completed | Phase 1 | 47 | Daiichi SankyoINDUSTRY | 1 | Jul 28, 2026 | clinicaltrials |
| NCT03556384 | Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) | completed | Phase 2 | 23 | Adam Burgoyne, MD, PhDOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT03581487 | Durvalumab, Tremelimumab, and Selumetinib in Treating Participants With Recurrent or Stage IV Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT03872778 | [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake(NeoRay) | completed | Phase 1 / Phase 2 | 35 | Advanced Accelerator ApplicationsINDUSTRY | 6 | Jul 28, 2026 | clinicaltrials |
| NCT04563871 | Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)(BLOSSOM) | completed | Phase 2 | 73 | Sehhoon ParkOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT05282901 | Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)(PLUME) | completed | Phase 2 | 51 | Institut CurieOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT05927558 | Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study | completed | — | 59 | Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT06029517 | A Sugar-Sweetened Beverage Reduction Intervention for Native American Men | completed | N/A | 48 | Roswell Park Cancer InstituteOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT06666556 | Bowel Preparation in Colonoscopy: Lactulose vs Polyethyleneglycol, Randomized Double-blind Comparative Clinical Trial, Multicenter Study. | completed | Phase 4 | 449 | Hospital Civil de GuadalajaraOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT07719933 | Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort Study | completed | — | 161 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 28, 2026 | clinicaltrials |
| NCT00429312 | A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma | completed | Phase 1 / Phase 2 | 10 | Jennerex BiotherapeuticsINDUSTRY | 1 | Jul 27, 2026 | clinicaltrials |
| NCT01339052 | Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma | completed | Phase 2 | 65 | L. Nicolas Gonzalez Castro, MD, PhDOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT01764529 | Modifiers of Disease Severity in Cerebral Cavernous Malformations | completed | — | 789 | University of California, San FranciscoOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT04975555 | Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy | completed | Phase 2 | 20 | University of Alabama at BirminghamOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT06604858 | Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer(TELESCOPE) | completed | Phase 2 | 31 | MedSIROTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT07725159 | Comparison of Lee-Huang Point and Umbilical Entry for Laparoscopic Success in Endometrial Cancer Patients(LEAP) | completed | N/A | 202 | Dr. Lutfi Kirdar Kartal Training and Research HospitalOTHER_GOV | 1 | Jul 27, 2026 | clinicaltrials |
| NCT00379340 | Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | completed | Phase 3 | 395 | Children's Oncology GroupNETWORK | 7 | Jul 24, 2026 | clinicaltrials |
| NCT02252887 | Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT02876302 | Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer | completed | Phase 2 | 23 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT03223753 | Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer | completed | Phase 3 | 299 | Children's Oncology GroupNETWORK | 2 | Jul 24, 2026 | clinicaltrials |
| NCT03384134 | Treating Pain in Children With Cancer: Pain Buddy | completed | N/A | 407 | University of California, IrvineOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT03672539 | Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome | completed | Phase 2 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT04208490 | Implementation and Effectiveness Trial of HN-STAR(HN-STAR) | completed | N/A | 357 | Wake Forest University Health SciencesOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT04235803 | Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery | completed | N/A | 78 | University of California, San FranciscoOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT04618913 | Anticoagulation in Patients With Venous Thromboembolism and Cancer(VICTORIE) | completed | — | 1 | PfizerINDUSTRY | 1 | Jul 24, 2026 | clinicaltrials |
| NCT05117957 | Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study | completed | Phase 2 | 50 | Bo Hyun KimOTHER_GOV | 1 | Jul 24, 2026 | clinicaltrials |
Data updated 24 days agoSource updated Jul 30, 2026source: clinicaltrials